[Impact of the COVID-19 pandemic on surgical activity within academic urological departments in Paris].

Impact de la pandémie de COVID-19 sur l’activité chirurgicale au sein des services d’urologie de l’Assistance Publique – Hôpitaux de Paris.

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Historique:
received: 20 04 2020
revised: 28 04 2020
accepted: 04 05 2020
pubmed: 21 5 2020
medline: 21 7 2020
entrez: 21 5 2020
Statut: ppublish

Résumé

As a result of the COVID-19 pandemic in France, all non-emergency surgical activity has been cancelled since March 12, 2020. In order to anticipate the reinstatement of delayed interventions, surgical activity reduction analysis is essential. The objective of this study was to evaluate the reduction of urological surgery in adult during the COVID-19 pandemic compared to 2019. The data regarding urological procedures realized in the 8 academic urological departments of Parisians centres (AP-HP) were compared over two similar periods (14-29 March 2019 and 12-27 March 2020) using the centralized surgical planning software shared by these centres. Procedure title, type of surgery and outpatient ratio were collected. The interventions were sorted into 16 major families of urological interventions. Overall, a 55% decrease was observed concerning urological procedures over the same period between 2019 and 2020 (995 and 444 procedures respectively). Oncology activity and emergencies decreased by 31% and 44%. The number of kidney transplantations decreased from 39 to 3 (-92%). Functional, andrological and genital surgical procedures were the most impacted among the non-oncological procedures (-85%, -81% and -71%, respectively). Approximatively, 1033 hours of surgery have been delayed during this 16-day period. Lockdown and postponement of non-urgent scheduled urological procedures decisions has led to a drastic decrease in surgical activity in AP-HP. Isolated kidney transplantation has been stopped (national statement). Urologists must anticipate for lockdown exit in order to catch-up delayed surgeries. 3.

Identifiants

pubmed: 32430140
pii: S1166-7087(20)30148-2
doi: 10.1016/j.purol.2020.05.001
pmc: PMC7211572
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

fre

Sous-ensembles de citation

IM

Pagination

439-447

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Références

Eur Urol. 2020 Jul;78(1):124-126
pubmed: 32349934
Semin Dial. 2018 Jan;31(1):82-87
pubmed: 28983956
Am J Manag Care. 2020 Apr;26(4):147-148
pubmed: 32270980
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
Lancet Oncol. 2020 Apr;21(4):467
pubmed: 32240603
J Am Coll Surg. 2020 Jun;230(6):1080-1091.e3
pubmed: 32240770
World J Urol. 1998;16(1):35-40
pubmed: 9542013
Urology. 2012 Mar;79(3):670-4
pubmed: 22386422
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Am J Transplant. 2020 Jul;20(7):1922-1924
pubmed: 32282991
Eur Urol. 2020 Jul;78(1):11-15
pubmed: 32307215
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Lancet. 2020 Feb 22;395(10224):542-545
pubmed: 32061313
Anesth Analg. 2020 Jul;131(1):37-42
pubmed: 32217947
Can J Anaesth. 2020 Jun;67(6):756-758
pubmed: 32144591
Eur J Emerg Med. 2020 Jun;27(3):174-177
pubmed: 32243317
Prog Urol. 2011 Oct;21(9):636-41
pubmed: 21943661
Prog Urol. 2020 Apr;30(5):221-231
pubmed: 32224294
J Pain Symptom Manage. 2020 Jul;60(1):e12-e14
pubmed: 32240756
Am J Transplant. 2020 Jul;20(7):1941-1943
pubmed: 32233067
Am J Transplant. 2020 Jan;20 Suppl s1:20-130
pubmed: 31898417
Lancet. 2020 Feb 29;395(10225):685-686
pubmed: 32059801
Eur Urol. 2019 Apr;75(4):702-703
pubmed: 30616943
BMJ. 1992 Sep 5;305(6853):577-9
pubmed: 1393041
Am J Transplant. 2020 Jul;20(7):1891-1895
pubmed: 32243673
Eur Urol. 2020 Jun;77(6):742-747
pubmed: 32249089

Auteurs

U Pinar (U)

GRC n(o) 5, PREDICTIVE ONCO-UROLOGY, hôpital Pitié-Salpêtrière, urologie, Sorbonne Université, AP-HP, 75013 Paris, France.

J Anract (J)

Servie d'urologie, hôpital Cochin, centre, université de Paris, AP-HP, 75014 Paris, France.

I Duquesne (I)

Servie d'urologie, hôpital Cochin, centre, université de Paris, AP-HP, 75014 Paris, France.

C Dariane (C)

Service d'urologie, hôpital européen Georges-Pompidou, centre, université de Paris, AP-HP, 75015 Paris, France.

E Chartier-Kastler (E)

Service d'urologie et de transplantation rénale, Hôpital Pitié-Salpêtrière, Sorbonne Université, AP-HP, 75013 Paris, France.

O Cussenot (O)

GRC n(o) 5, PREDICTIVE ONCO-UROLOGY, hôpital Tenon, urologie, Sorbonne Université, AP-HP, 75020 Paris, France.

F Desgrandchamps (F)

Service d'urologie, hôpital Saint-Louis, université de Paris, AP-HP, nord, 75010 Paris, France; CEA/SRHI, U976 HIPI, institut de recherche Saint-Louis, université de Paris, Paris, France.

J-F Hermieu (JF)

Service d'urologie, hôpital Bichat, université de Paris, AP-HP, Nord, 75010 Paris, France.

J Irani (J)

Service d'urologie, hôpital Bicêtre, université Paris Saclay, AP-HP, 94270 Le Kremlin-Bicêtre, France.

A de La Taille (A)

Service d'urologie, hôpital Henri-Mondor, hôpitaux universitaires Henri-Mondor, AP-HP, 94010 Créteil, France.

A Méjean (A)

Service d'urologie, hôpital européen Georges-Pompidou, centre, université de Paris, AP-HP, 75015 Paris, France.

P Mongiat-Artus (P)

Service d'urologie, hôpital Saint-Louis, université de Paris, AP-HP, nord, 75010 Paris, France.

M Peyromaure (M)

Servie d'urologie, hôpital Cochin, centre, université de Paris, AP-HP, 75014 Paris, France.

B Barrou (B)

Service d'urologie et de transplantation rénale, Hôpital Pitié-Salpêtrière, Sorbonne Université, AP-HP, 75013 Paris, France.

M Zerbib (M)

Service d'urologie, centre, hôpital Cochin, université de Paris, AP-HP, 75014 Paris, France.

M Rouprêt (M)

GRC n(o) 5, PREDICTIVE ONCO-UROLOGY, hôpital Pitié-Salpêtrière, urologie, Sorbonne Université, AP-HP, 75013 Paris, France. Electronic address: morgan.roupret@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH